TELA (TELA Bio) Tariff Resilience Score: 5/10 (As of Jul. 12, 2026)


TELA TELA Bio Inc TELA
59 GF Score
Price $0.85
GF Value $1.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is TELA Bio Tariff Resilience Score?

TELA Bio TELA -1.28% 59 Tariff Resilience Score is 5 as of Jul. 12, 2026. GuruFocus rates TELA with a GF Score™ of 59/100 and a GF Value™ of $1.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 835 Medical Devices & Instruments companies, TELA Bio ranks better than 79.28% on this metric.

TELA Bio has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

TELA Bio has TELA Bio's medical devices are subject to tariffs on imported materials. While the company can explore alternative suppliers, its niche market limits pricing flexibility, increasing tariff vulnerability.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes TELA Bio might have Average Resilient.

TELA Bio  (NAS:TELA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

TELA Bio Tariff Resilience Score Related Terms

TELA vs NSPR, BDMD, PAVM: Tariff Resilience Score Comparison

For the Medical Devices subindustry, TELA Bio's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TELA Bio Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TELA Bio's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where TELA Bio's Tariff Resilience Score falls into.


TELA
59GF Score
TELA Bio Inc TELA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
TELA Bio (TELA) has a Tariff Resilience Score of 5 as of Jul. 12, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, TELA Bio ranks #173 out of 835 companies in the Medical Devices & Instruments industry, placing it in the top 20.7%.
Is TELA Bio's Tariff Resilience Score too high?
TELA Bio's current Tariff Resilience Score is 5. Based on the distribution chart, TELA Bio ranks #173 out of 835 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TELA Bio has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TELA Bio's Tariff Resilience Score compare to NSPR and BDMD?
According to the Medical Devices & Instruments industry distribution chart, TELA Bio ranks #173 out of 835 companies for Tariff Resilience Score. This places TELA Bio in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. TELA Bio's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TELA Bio stock overvalued right now?
Based on GuruFocus' analysis, TELA Bio (TELA) is currently considered Possible Value Trap. The stock's GF Value™ is $1.66, compared to a current price of $0.85 — trading 49% below its estimated fair value. The current Tariff Resilience Score is 5. TELA Bio's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For TELA Bio (TELA), the current Tariff Resilience Score is 5 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TELA Bio (TELA) Overvalued in 2026?

Based on GuruFocus' analysis, TELA Bio stock appears to be undervalued. The current stock price of $0.85 is trading 49% below its estimated GF Value™ of $1.66. GuruFocus considers TELA Bio to be Possible Value Trap.

Key valuation signals for TELA:

  • Tariff Resilience Score: 5
  • GF Value™: $1.66 vs. price of $0.85 (49% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TELA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TELA Bio Business Description

Address 1 Great Valley Parkway, Suite 24, Malvern, PA, USA, 19355
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
59GF Score

Get the complete analysis for TELA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.85
Price
$1.66
GF Value